A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer

Kosei Hasegawa, Muneaki Shimada, Satoshi Takeuchi, Hiroyuki Fujiwara, Yuichi Imai, Norihiro Iwasa, Satoru Wada, Hidetaka Eguchi, Tetsuro Oishi, Toru Sugiyama, Mitsuaki Suzuki, Masahiko Nishiyama, Keiichi Fujiwara

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences